TABLE 3.
Comparative susceptibilities to six fluoroquinolones and distribution of MICs among isolatesa
MIC (mg/liter) | % of strains or relative MICb
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Moxifloxacin
|
Gatifloxacin
|
Sitafloxacin
|
Ofloxacin
|
Levofloxacin
|
Sparfloxacin
|
|||||||||||||||||||
C | S | R− | R+ | C | S | R− | R+ | C | S | R− | R+ | C | S | R− | R+ | C | S | R− | R+ | C | S | R− | R+ | |
≤0.125 | 16 | 17 | 24 | 13 | 33 | 39 | 16 | 100 | 83 | 26 | ||||||||||||||
0.25 | 100 | 61 | 43 | 100 | 61 | 65 | 100 | 55 | 26 | 100 | 31 | 100 | 60 | 4 | 13 | 61 | 3 | |||||||
0.5 | 16 | 30 | 12 | 13 | 10 | 26 | 22 | 40 | 22 | 52 | 4 | 9 | 19 | |||||||||||
1 | 6 | 9 | 31 | 1 | 4 | 16 | 1 | 9 | 34 | 29 | 2 | 35 | 3 | 9 | ||||||||||
2 | 1 | 53 | 4 | 44 | 25 | 83 | 3 | 9 | 22 | 4 | 28 | |||||||||||||
4 | 13 | 1 | 41 | 16 | 13 | 19 | 25 | 22 | ||||||||||||||||
8 | 3 | 3 | 4 | 28 | 31 | |||||||||||||||||||
16 | 38 | 19 | 19 | |||||||||||||||||||||
>16 | 13 | |||||||||||||||||||||||
MIC50 | 1 | 1 | 1 | 8 | 1 | 1 | 1 | 8 | 1 | 1 | 1 | 4 | 1 | 2 | 8 | 32 | 1 | 1 | 2 | 16 | 1 | 1 | 2 | 16 |
MIC90 | 1 | 2 | 2 | 16 | 1 | 2 | 2 | 16 | 1 | 2 | 2 | 16 | 1 | 4 | 16 | >64 | 1 | 2 | 4 | 16 | 1 | 2 | 4 | 128 |
There were four categories of M tuberculosis strains: C, the two ATCC control strains; S, 83 ofloxacin-susceptible strains (ofloxacin MIC < 2 mg/liter); R−, 23 ofloxacin-resistant isolates without gyrA mutations (ofloxacin MIC ≥ 2mg/liter); and R+, 32 ofloxacin-resistant isolates with gyrA mutations (ofloxacin MIC ≥ 2mg/liter).
See Table 2, footnote a.